CN1405172A - Lactosamino fat, preparation method and application thereof - Google Patents
Lactosamino fat, preparation method and application thereof Download PDFInfo
- Publication number
- CN1405172A CN1405172A CN01127323A CN01127323A CN1405172A CN 1405172 A CN1405172 A CN 1405172A CN 01127323 A CN01127323 A CN 01127323A CN 01127323 A CN01127323 A CN 01127323A CN 1405172 A CN1405172 A CN 1405172A
- Authority
- CN
- China
- Prior art keywords
- lactose
- fat
- lactosamino
- alkyl
- amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A kind of lactose amine grease is disclosed in the invention, whose characters are: its chemically name is N-12 alkyl-N(beta-D-lactose) acetamide; lactose and long chain amine processes amination reaction in the medium of isopropanol and creates N-alkyl-beta-lactose amine firstly, and then processing O-and N-acetylation, putting off O-acetyl and getting N-alkyl (beta-D-lactose) acetamide in the quantitative sodium methoxide action lastly. The lactose amine grease has characters of antinubble and antitransfer activity to Lewis lung cancer.
Description
The present invention relates to a kind of Lactosamino fat and press down application in knurl and the anti-metastasis in Louis (Lewis) lung cancer.
Transfer is that malignant tumour is brought a key property of bigger harm to people, stops metastases to become the focus of treatment cancer.According to document (1, Natori, T.; Morita, M.; Akimoto, K.; Koezuka, Y.; Agelasphins, Novel Antitumor and ImmunostimulatoryCerebroside from the Marine Sponge Agelas Mauritianus.Tetrahedron, 1994,50,2771-2784; 2, Akimoto, K.; Koezuka, Y.; Higa, T.Agelasphins, Novel Galactosylceramides from the Marine Sponge Agelas Mauritianus.Tetrahedron Lett.1993,34,5591-92) report, sphingoglycolipid has the effect of blocking-up metastases, yet the synthesis step of sphingoglycolipid is loaded down with trivial details, yield and stereoselectivity are lower, therefore, the analogue of design, searching and simulation sphingoglycolipid chain, exploitation is efficient, the antitumor drug of low toxicity becomes pharmacy circle and the focus of chemical boundary research.
The purpose of this invention is to provide a kind of Lactosamino fat, it is a kind of new compound, and Lewis lung cancer is had the knurl and the antimetastatic activity of pressing down, and can remedy the above-mentioned deficiency of prior art.
A kind of Lactosamino fat, the chemical name that it is characterized in that it are N-alkyl-(β-D-lactose base) ethanamide, and molecular formula is C
26H
49NO
11, structural formula is
A kind of method for preparing Lactosamino fat is characterized in that at first in the medium of Virahol and water, lactose and long-chain fat amine carry out aminated reaction, generates N-alkyl-beta lactose amine; Under the effect of pyridine and acetic anhydride, carry out O-and N-acetylization reaction then, last, under the effect of sodium methylate, optionally take off the O-ethanoyl.
A kind of Lactosamino fat is characterized in that it is used for Lewis lung cancer and presses down knurl and anti-metastasis.
Lactosamino fat of the present invention can obviously suppress the generation of Lewis lung cancer in the scope of 25mg, two dosages of 50mg, its maximum tumour inhibiting rate is 42.3%, and can obviously suppress the transfer of lung cancer, obvious effective rate, P<0.05.
Below by embodiment the present invention is described.
When preparing osamine fat of the present invention, at first in the medium of 500ml Virahol and 300ml water, add 25g lactose and 23g long-chain fat amine, stirred 24 hours under the room temperature, under 60 ℃, carry out aminated reaction, generate N-alkyl-beta lactose amine; Under the effect of 200ml pyridine and 100ml acetic anhydride, under room temperature condition, carry out O-and N-acetylization reaction then; At last, under the effect of the sodium methylate of 0.2g, optionally take off the O-ethanoyl, obtain N-alkyl-N-(β-D-lactose base) ethanamide, be called for short Lactosamino fat, its molecular formula is C
26H
49NO
11, structural formula is
Claims (3)
2, a kind of method for preparing Lactosamino fat is characterized in that at first in the medium of Virahol and water, lactose and long-chain fat carry out aminated reaction, generates N-alkyl-beta lactose amine; Under the effect of pyridine and acetic anhydride, carry out O-and N-acetylization reaction then, last, under the effect of sodium methylate, optionally take off the O-ethanoyl.
3, a kind of Lactosamino fat is characterized in that it is used for Lewis lung cancer and presses down knurl and anti-metastasis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01127323A CN1405172A (en) | 2001-08-13 | 2001-08-13 | Lactosamino fat, preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01127323A CN1405172A (en) | 2001-08-13 | 2001-08-13 | Lactosamino fat, preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1405172A true CN1405172A (en) | 2003-03-26 |
Family
ID=4667291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN01127323A Pending CN1405172A (en) | 2001-08-13 | 2001-08-13 | Lactosamino fat, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1405172A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103748103A (en) * | 2011-01-05 | 2014-04-23 | 台湾大学 | Methods for preparation of glycosphingolipids and uses thereof |
CN104655859A (en) * | 2013-11-21 | 2015-05-27 | 苏州中赢医疗科技有限公司 | Breast cancer diagnosis marker |
CN104812769A (en) * | 2012-10-30 | 2015-07-29 | Abivax公司 | Method of preparation of alpha-galactosyl ceramides compounds |
CN104910218A (en) * | 2014-03-14 | 2015-09-16 | 中国科学院微生物研究所 | Neoglycospingolipid compound, preparation method and application thereof |
-
2001
- 2001-08-13 CN CN01127323A patent/CN1405172A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103748103A (en) * | 2011-01-05 | 2014-04-23 | 台湾大学 | Methods for preparation of glycosphingolipids and uses thereof |
US9181292B2 (en) | 2011-01-05 | 2015-11-10 | Pi-Hui Liang | Methods for preparation of glycosphingolipids and uses thereof |
US10654880B2 (en) | 2011-01-05 | 2020-05-19 | Pi-Hui Liang | Methods for preparation of glycosphingolipids and uses thereof |
CN104812769A (en) * | 2012-10-30 | 2015-07-29 | Abivax公司 | Method of preparation of alpha-galactosyl ceramides compounds |
CN109503682A (en) * | 2012-10-30 | 2019-03-22 | Abivax公司 | Prepare α-galactosylceramide compound method |
US10870671B2 (en) | 2012-10-30 | 2020-12-22 | Abivax | Method of preparation of alpha galactosyl ceramides compounds |
CN109503682B (en) * | 2012-10-30 | 2023-07-07 | Abivax公司 | Process for preparing alpha-galactosyl ceramide compound |
CN104655859A (en) * | 2013-11-21 | 2015-05-27 | 苏州中赢医疗科技有限公司 | Breast cancer diagnosis marker |
CN104910218A (en) * | 2014-03-14 | 2015-09-16 | 中国科学院微生物研究所 | Neoglycospingolipid compound, preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE499377T1 (en) | SYNTHESIS OF EPIRUBICIN FROM 13-DIHYDRODAUNORUBICIN | |
BRPI0413323A (en) | process for the preparation of polysaccharide-protein conjugate vaccines | |
WO2005021523A8 (en) | Piperazine substituted compounds used as calcium channel blockers | |
HK1098125A1 (en) | Indane acetic acid compounds | |
CA2512847A1 (en) | Conjugates obtained by reductive amination of serotype 5 pneumococcus capsular polysaccharide | |
CN1405172A (en) | Lactosamino fat, preparation method and application thereof | |
GB0102239D0 (en) | Methods of chemical synthisis | |
DE60201890D1 (en) | SYNTHESIS OF BETA-LAPACHONE AND RELATED INTERIM PRODUCTS | |
DK1727817T3 (en) | Azabicyclooctan-3-undivatives and their use | |
Singh et al. | An improved synthesis of urea derivatives from N-acylbenzotriazole via curtius rearrangement | |
ATE399165T1 (en) | QUINOLINE COMPOUNDS AND USES THEREOF | |
Joy et al. | A rapid and modified approach for C-7 amination and amidation of 4-methyl-7-nonafluorobutylsulfonyloxy coumarins under microwave irradiation | |
DE50211983D1 (en) | GANIC MATERIAL | |
DE60325377D1 (en) | MOTILIDVERBINDUNGEN | |
Chen et al. | Desulfurization and transformation of isothiocyanates to cyanamides by using sodium bis (trimethylsilyl) amide | |
CY1107362T1 (en) | IMIDAZOLYLI PRODUCTS USEFUL AS HINAMINE H3 CONNECTOR CONNECTORS | |
IL170657A (en) | 2- nitromethylpyridine derivatives and process for the preparation of 2-nitromethylpyridine derivatives and 2-aminomethylpyridine derivatives | |
Liu et al. | Photo-induced radical cyclization of aromatic halides with sodium borohydride | |
WO2006077397A3 (en) | Method of producing conjugate vaccines | |
MXPA05013604A (en) | Process for preparing acylsulfamoylbenzamides. | |
DK1334176T3 (en) | Microorganisms producing L-glutamine and methods for producing L-glutamine using the same | |
Liav et al. | N‐Glycosyl‐N′‐[p‐(isoamyloxy) phenyl]‐thiourea Derivatives: Potential Anti‐TB Therapeutic Agents | |
PT1599446E (en) | An improved process for the preparation of gabalactam | |
ATE354376T1 (en) | COMPOSITIONS FOR ELECTROPORATION | |
RU2218322C1 (en) | Method for preparing aryl-substituted acetylindanediones-1,3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |